Over the past three months, The New York Times has covered stories on the local impact of synthetic-drug use. In July, they published a story on the synthetic-drug problem that has been growing in the Syracuse region. On Sept. 2, they reported on the dramatic spike in the use of K2, synthetic marijuana, in Harlem […]
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
Over the past three months, The New York Times has covered stories on the local impact of synthetic-drug use. In July, they published a story on the synthetic-drug problem that has been growing in the Syracuse region. On Sept. 2, they reported on the dramatic spike in the use of K2, synthetic marijuana, in Harlem and in other parts of New York City.
The most-recent article noted that one particular city block in Harlem “appears at times to be a street of zombies.” K2, which is banned by the New York State Department of Health, is one of several synthetic drugs that are plaguing New York City, Central New York, and other parts of the state. Because the Department of Health’s ban does not go far enough to penalize selling synthetic drugs, it has left local communities grappling with increased synthetic-drug use and health and safety issues. I have long advocated for criminalizing the sale of synthetic drugs and have introduced legislation to that effect.
Outlawing synthetic drugs has been a challenge because New York and the federal government outlaw drugs based on their chemical compounds. Because they are synthetics, manufacturers have been able to slightly change their chemical composition, so that they are no longer on the state’s controlled-substance list, and therefore, no longer illegal. In addition, synthetic drugs are often mislabeled and sold as products other than drugs (i.e., bath salts, shoe deodorant, and incense). However, the seller and the purchaser realize that the intended use of the synthetic drug is to provide a high for the user.
My legislation addresses mislabeling, chemical swapping, and creates penalties for possessing and selling a synthetic-drug equivalent to the “street drug” counterpart. The bill contains two key provisions: (1) broader power is given to the Commissioner of Health to add synthetic drugs and their chemical compounds to the controlled-substance list, rather than having the state legislature act to add to the controlled-substance list; and (2) stores will be penalized for selling mislabeled products when they are clearly intended to be used as drugs. State Senator Patty Ritchie is the prime sponsor of this legislation in the State Senate.
For reasons unknown, Assembly Democrats in the New York Assembly have continually blocked my legislation from getting to the floor of the Assembly for a vote. It is time for the Assembly Democrats to recognize the dangers of synthetic drugs and take action. They need to stop blocking legislation that will not only protect the citizens of the New York City area, but also all citizens of New York state from the evils of these drugs.
William (Will) A. Barclay is the Republican representative of the 120th New York Assembly District, which encompasses most of Oswego County, including the cities of Oswego and Fulton, as well as the town of Lysander in Onondaga County and town of Ellisburg in Jefferson County. Contact him at barclaw@assembly.state.ny.us, or (315) 598-5185.